Shares of Livent Co. (NYSE:LTHM – Get Rating) received an average rating of “Hold” from the twelve research firms that currently cover the stock, MarketBeat.com reports. One investment analyst rated the stock with a sell recommendation, four assigned a hold recommendation and five gave the company a buy recommendation. The 12-month average price target among brokerages that have covered the stock over the past year is $29.33.
LTHM has been the subject of several analyst reports. Bank of America upgraded Livent from an “underperforming” rating to a “neutral” rating in a Tuesday, Feb. 1 research note. Goldman Sachs Group cut its price target on Livent from $23.00 to $20.00 and set a “sell” rating for the company in a Tuesday, March 1 research note. Vertical Research upgraded Livent from a “hold” rating to a “buy” rating and set a price target of $30.00 for the company in a Tuesday, January 4, research note. Mizuho reduced its price target on Livent from $31.00 to $26.00 and set a “neutral” rating for the company in a Wednesday, February 23 research note. Finally, Zacks Investment Research downgraded Livent from a “buy” rating to a “hold” rating in a Friday, February 18 research note.
NYSE:LTHM opened at $25.40 on Friday. The company has a debt ratio of 0.30, a current ratio of 3.04 and a quick ratio of 2.02. The company has a market capitalization of $4.11 billion, a price-earnings ratio of -1,270.00, a growth price-earnings ratio of 1.22 and a beta of 2.03. Livent has a one-year low of $15.87 and a one-year high of $33.04. The company has a fifty-day moving average price of $23.58 and a 200-day moving average price of $25.21.
Livent (NYSE:LTHM – Get Rating) last released its quarterly earnings data on Thursday, February 17. The company reported EPS of $0.08 for the quarter, beating the consensus estimate of $0.07 by $0.01. The company posted revenue of $122.90 million in the quarter, compared to analyst estimates of $104.47 million. Livent had a return on equity of 4.63% and a net margin of 0.14%. During the same period of the previous year, the company posted an EPS of ($0.02). On average, equity research analysts expect Livent to post earnings per share of 0.62 for the current fiscal year.
A number of institutional investors have been buying and selling stocks recently. Bessemer Group Inc. increased its position in Livent shares by 77.7% during the fourth quarter. Bessemer Group Inc. now owns 1,189 shares of the company worth $29,000 after acquiring an additional 520 shares during the period. Mariner LLC increased its position in Livent shares by 1.1% during the third quarter. Mariner LLC now owns 50,153 shares of the company worth $1,159,000 after acquiring an additional 546 shares during the period. Choate Investment Advisors increased its position in Livent shares by 3.7% during the third quarter. Choate Investment Advisors now owns 15,496 shares of the company worth $358,000 after acquiring an additional 555 shares during the period. Virtue Capital Management LLC increased its position in Livent shares by 0.9% during the fourth quarter. Virtue Capital Management LLC now owns 66,016 shares of the company worth $1,609,000 after acquiring an additional 581 shares during the period. Finally, Texas Permanent School Fund increased its position in Livent shares by 0.5% during the third quarter. Texas Permanent School Fund now owns 119,498 shares of the company worth $2,762,000 after acquiring an additional 585 shares during the period. 93.05% of the shares are currently held by institutional investors.
Livent Company Profile (Get a rating)
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and Asia- Peaceful. The company offers lithium compounds for use in applications requiring specific performance, including battery-grade lithium hydroxide for use in high-performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceuticals, as well as a range of specialty lithium compounds, including high-purity lithium metal, which is used in non-rechargeable batteries and materials production lightweight for aerospace applications.
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Livent right now?
Before you consider Livent, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Livent wasn’t on the list.
Although Livent currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here